Shusuke Kawashima

5PUBLICATIONS

39CO-AUTHORS

Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 11, 2026

Phenotypic Analysis of 26 Cultured TILs Derived From Japanese Melanoma Tissues.

|Jul 31, 2025

PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy.

Katsushige Kawase, Shusuke Kawashima, Tatsuya Nishi

|Aug 21, 2024

Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.

Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino

|Apr 18, 2024

CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.

Yuto Naoi, Takao Morinaga, Joji Nagasaki

|Apr 16, 2023

High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects.

Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki

Pageof 1

Frequent Collaborators

Katsushige Kawase

Takashi Inozume

Masahito Kawazu

Yosuke Togashi

Toyoyuki Hanazawa

Tatsuyoshi Kawamura

Joji Nagasaki

Yasuhiro Nakamura

Takao Morinaga

Youki Ueda

Frequent Collaborators

Katsushige Kawase

Takashi Inozume

Masahito Kawazu

Yosuke Togashi